- /
- Supported exchanges
- / US
- / SMMNY.PINK
Siemens Healthineers AG ADR (SMMNY PINK) stock market data APIs
Siemens Healthineers AG ADR Financial Data Overview
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers in Germany, the United States, rest of Europe, CIS, Africa, the Middle East, the Americas, the Asia Pacific, Japan, and China. It operates in four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment offers magnetic resonance imaging, computed tomography, X-ray, molecular imaging, and ultrasound systems; and software solutions to support the reading and structured reporting of diagnostic images from different modalities. Its Diagnostics segment provides in-vitro diagnostic products and services to healthcare providers in the fields of general and specialty laboratory, and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment offers microwave, cryoablation, and embolization technologies, as well as clinical professional services for cancer care that support oncology departments in hospitals and clinics; and customized support for cancer care operations. Its Advanced Therapies segment provides products that are designed to support image-guided minimally invasive clinical procedures in various areas, such as cardiology, neurology, and oncology; angiography systems and mobile C-arms; and AI-powered clinical applications. It also offers essential technical customer service, such as maintenance and repair; spare parts; medical equipment performance management; training; clinical education and e-learning; planning and design; financing; asset management; and managed departmental services for laboratories and healthcare facilities, as well as healthcare consulting, products, and services. The company was founded in 1896 and is headquartered in Forchheim, Germany. Siemens Healthineers AG is a subsidiary of Siemens Aktiengesellschaft.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Siemens Healthineers AG ADR (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Siemens Healthineers AG ADR data using free add-ons & libraries
Get Siemens Healthineers AG ADR Fundamental Data
Siemens Healthineers AG ADR Fundamental data includes:
- Net Revenue: 23 295 M
- EBITDA: 4 048 M
- Earnings Per Share: 1
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-02-05
- EPS/Forecast: 0.2679
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Siemens Healthineers AG ADR News
New
Has Siemens Healthineers (XTRA:SHL) Fallen Too Far After Recent Share Price Weakness?
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. If you are wondering whether Siemens Healthineers at €4...
AI in Oncology Research and Long-term Forecasts Report 2026-2040: Siemens Healthineers and GE Healthcare Lead, While NVIDIA, IBM, Tempus, PathAI, and Emerging Specialists Expand Use Cases
Company Logo AI in oncology is poised to revolutionize cancer care through early, accurate detection, and personalized treatment, driven by rising cancer rates. Key opportunities include AI-enhanced ...
Siemens Healthineers AG (SMMNY) Q1 2026 Earnings Call Highlights: Strong Imaging and Precision ...
This article first appeared on GuruFocus. Imaging Revenue Growth: 5.7% growth driven by photon-counting CT and Radiopharmaceuticals business. Precision Therapy Revenue Growth: 5.9% growth, with Varia...
Preclinical Imaging Market to Reach US$ 3,332.2 Million by 2033 Driven by Rising Cell & Gene Therapy R&D, High-Throughput In-Vivo Imaging, and AI-Enabled Multimodal Platforms | Astute Analytica
AstuteAnalytica India Pvt. Ltd. The global preclinical imaging market is experiencing significant growth, propelled by increased R&D spending, adoption of non-invasive, high-resolution technologies, ...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.